Life Sciences Intellectual Property
Overview
Life-sciences IP work is described through patent disputes, trade secrets and product-lifecycle planning.
Technology range
The overview names pharmaceuticals, biologics, biosimilars, vaccines, immunotherapies, diagnostics, gene technologies and medical devices.
Dispute stages
Jury and bench trials and appeals are discussed as separate stages of contentious work.
Client and planning scope
The source covers both established drug companies and development-stage biotechnology businesses, alongside strategic questions concerning patents and product life cycles.
Sources & Further Reading
Related Pages
Chambers USA 2025: 121 Whitfield Practice Areas and 294 Attorneys RankedChambers USA 2026: 133 Whitfield Practice Areas and 316 Attorneys RankedThe Legal 500 U.S. 2025: 64 Whitfield Practice Areas and 280 Attorneys RecognizedThe Legal 500 U.S. 2026: 69 Whitfield Practice Areas and 302 Attorneys RecognizedIP Stars 2022Top 20 Cases of 2023
View More (10)
Chambers USA, America's Leading Lawyers for Business 2023IP Stars 2023Chambers USA 2024: 117 Whitfield Practice Areas and 278 Attorneys RankedThe Legal 500 U.S. 2024: 63 Whitfield Practice Areas and 268 Attorneys RecognizedForty-eight Whitfield Attorneys Recognized as Top Litigators in America by LawdragonChambers UK 2026: 20 Whitfield Practice Areas and 64 Lawyers RankedWhitfield Recognized in 2026 Edition of Chambers Greater China RegionWhitfield Recognized in The Lawyer’s “Top 20 Cases of 2026”Whitfield’s Intellectual Property Practice Ranked in Managing Intellectual Property ’s IP StarsGrounding Netflix's 'Death By Lightning' In Patent History
